Friday, January 27th, 2012

Stem Cell Eye Therapy Shows Promise

Steven Schwartz of UCLA peers into a microscope during surgery to transplant specialized retinal pigment epithelial cells derived from human embryonic stem cells into the eyes of patients enrolled in clinical trials. Photo by Reed Hutchinson/UCLA.

Reporting inThe Lancet, researchers write that a preliminary study shows embryonic stem cell therapy in two patients with macular degeneration was safe. Results suggest the patients’ vision improved slightly. Co-author, Advanced Cell Technology’s Dr. Robert Lanza discusses the trial.

Guests

Robert Lanza
Chief Scientific Officer
Advanced Cell Technology
Marlborough, Massachusetts

Related Links

• The Lancet: Embryonic stem cell trials for macular degeneration: a preliminary report

Segment produced by:Namisha Sarin Anand

Friday, January 27th, 2012

• Magnetic Soap May Help Clean Up Spilled Oil
• How ‘Space Weather’ Affects Planes And Power Grids
• A Mobile Wallet: Cash, Credit, Or... Cell Phone?
• Ode To Ice
• Stem Cell Eye Therapy Shows Promise
• Can Science Be Done Without Secrecy?
• Ancient Skull Holds Clues to Dog Domestication

Elsewhere on Sciencefriday.com

Explore More

• Biotechnology
• Diseases and Conditions
• Medical Research